A carregar...
Could valproic acid be an effective anticancer agent? The evidence so far
Valproic acid is an inhibitor of class I histone deacetylases. Epigenetic therapies in cancer have been focus of a keen interest and HDAC inhibitors in particular have been approved for certain types of hematologic malignancies. Valproic acid is an attractive candidate for cancer therapy due to its...
Na minha lista:
| Publicado no: | Expert Rev Anticancer Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4579528/ https://ncbi.nlm.nih.gov/pubmed/25017212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2014.940329 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|